Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1984 Jul;60(705):482–484. doi: 10.1136/pgmj.60.705.482

Development of Hodgkin's disease in the course of liver cirrhosis and impaired monocyte function.

M Dan, A Hassner, M Jedwab, S Shibolet
PMCID: PMC2417944  PMID: 6463000

Abstract

The monocyte function, as measured by phagocytosis and killing of Candida albicans and Candida pseudotropicalis by peripheral blood monocytes, was found impaired in a patient with cirrhosis of the liver on two separate determinations before the occurrence of bleeding from oesophageal varices. Unexpectedly, Hodgkin's disease was diagnosed in enlarged abdominal lymph nodes found on the occasion of an emergency portocaval shunt operation.

Full text

PDF
482

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjorneboe M., Prytz H., Orskov F. Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver. Lancet. 1972 Jan 8;1(7741):58–60. doi: 10.1016/s0140-6736(72)90060-8. [DOI] [PubMed] [Google Scholar]
  2. Cline M. J., Lehrer R. I., Territo M. C., Golde D. W. UCLA Conference. Monocytes and macrophages: functions and diseases. Ann Intern Med. 1978 Jan;88(1):78–88. doi: 10.7326/0003-4819-88-1-78. [DOI] [PubMed] [Google Scholar]
  3. Harris C. C. The carcinogenicity of anticancer drugs: a hazard in man. Cancer. 1976 Feb;37(2 Suppl):1014–1023. doi: 10.1002/1097-0142(197602)37:2+<1014::aid-cncr2820370805>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  4. Hassner A., Kletter Y., Jedvab M., Aronson M., Shibolet S. Impaired monocyte function in liver cirrhosis. Lancet. 1979 Feb 10;1(8111):329–330. doi: 10.1016/s0140-6736(79)90745-1. [DOI] [PubMed] [Google Scholar]
  5. Heimann R. Cirrhoses et lymphopathies malignes. Acta Gastroenterol Belg. 1971 Oct;34(10):663–675. [PubMed] [Google Scholar]
  6. METCALF D. Reticular tumours in mice subjected to prolonged antigenic stimulation. Br J Cancer. 1961 Dec;15:769–779. doi: 10.1038/bjc.1961.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Miller D. G. The association of immune disease and malignant lymphoma. Ann Intern Med. 1967 Mar;66(3):507–521. doi: 10.7326/0003-4819-66-3-507. [DOI] [PubMed] [Google Scholar]
  8. Prytz H., Bjorneboe M., Christoffersen P., Poulsen H., Orskov F. Correlation between hepatic morphology and immunoglobulins and antibodies to Escherichia coli in cirrhosis. Gut. 1977 Jan;18(1):28–32. doi: 10.1136/gut.18.1.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sherlock S. Immunological changes in liver disease. Proc R Soc Med. 1977 Dec;70(12):851–855. doi: 10.1177/003591577707001207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Slavin S., Zlotnick A., Levij I. S., Eliakim M. Clinical implications of monoclonal gammopathy in chronic liver disease. Am J Dig Dis. 1974 Mar;19(3):223–234. doi: 10.1007/BF01072539. [DOI] [PubMed] [Google Scholar]
  11. Territo M. C., Cline M. J. Monocyte function in man. J Immunol. 1977 Jan;118(1):187–192. [PubMed] [Google Scholar]
  12. Viteri A., Vernace S. J., Schaffner F. Extrahepatic malignancy in chronic liver disease: report of six cases. Gastroenterology. 1976 Dec;71(6):1075–1078. [PubMed] [Google Scholar]
  13. Wands J. R., Chura C. M., Roll F. J., Maddrey W. C. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology. 1975 Jan;68(1):105–112. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES